The Chromophobe RCC Research Grant Award supports researchers studying a rare kidney cancer, funding innovative work shaped by patient priorities to generate preliminary data and pursue clinical impact.
The KCA Awards Program supports kidney cancer investigators with research on disease biology, treatment vulnerabilities and lifestyle factors to improve care and guide future work.
Supports innovative research to discover and investigate new targets or biomarkers for kidney cancer, encouraging basic, translational, and clinical science that could lead to new treatments.
Advanced Clinical Research Award supports independent mid-career physicians pursuing original breast cancer clinical or human-subjects translational research to address patient needs and potential benefit.
Childhood Cancer Research Grants support investigators, including beginning scientists and physician-scientists, in targeted research to improve childhood cancer survival while protecting long-term health.
AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants support researchers studying druggable targets and biomarkers to advance new kidney cancer treatments, diagnosis, monitoring, and prognosis.